Page 6 - Astellas Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global $94B+ Vaccines Market Outlook, 2024-2030 by Type,

Global $94B+ Vaccines Market Outlook, 2024-2030 by Type,
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesEmergent biosolutions incSanofi groupDevelopment of therapeutic vaccinesHigh developmentBharat biotech ltdEuropean unionAfrica vaccine acquisitionTechnology typeNovavax incRoute of administrationRising developmentJohnson services incModerna incMerck kgaaPolicies for vaccine development

Enzalutamide Improves Undetectable PSA Rates Alone and With Leuprolide in Nonmetastatic CSPC

Enzalutamide alone and with leuprolide led to greater rates of undetectable PSA levels vs leuprolide alone in castration-sensitive prostate cancer.

United statesAmerican urological association annual meetingSumitomo pharma america incAstellas pharma incPfizer incDendreon pharmaceuticalsMyovant sciences incUrological association annualJohnson innovative medicineSumitomo pharma americaMyovant sciencesProstate cancer

Meticulous Market Research Pvt Ltd : Pharmaceutical Packaging Market to Be Worth $176 54 Billion by 2031

Meticulous Market Research Pvt Ltd : Pharmaceutical Packaging Market to Be Worth $176 54 Billion by 2031
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSwitzerland generalSouth koreaZwei rohstoff chancenEurope roAsia pacific roExperte carsten storkCatalent incPharmascience incAptargroup incDrug plastics groupServices incMeticulous researchUnited nationsLiveo research switzerlandAstellas pharma inc

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology

- Leverages Poseida s proprietary allogeneic CAR-T platform to develop innovative convertibleCAR® programs targeting solid tumors - TOKYO and SAN DIEGO, May 1, 2024 /PRNewswire/ Astellas.

Xyphos biosciencesAstellas pharmaKristin yaremaNaoki okamuraAdam pearsonAstellas companyPoseida therapeutics incExchange commissionXyphos biosciences incAreas of interest astellas pharma incAstellas pharma incPoseida therapeuticsChimeric antigen receptorChief strategy officerPrimary focusFocus area approach

China implements law to strengthen control on state secrets

China implements a revised law on guarding state secrets that is expected to help Beijing further safeguard national security following the entry into force of an amended counterespionage law in July last year.

Chen yixinAstellas pharma incCommunist partyAstellas pharmaState security minister chen yixinChina newsChina national securityHina state secretHina news lawHina strengthen control